Cargando…

Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan

BACKGROUND: Pyrazinamide (PZA) is an important component of first-line drugs because of its distinctive capability to kill subpopulations of persistent Mycobacterium tuberculosis (MTB). The prodrug (PZA) is converted to its active form, pyrazinoic acid (POA) by MTB pncA-encoded pyrazinamidase (PZase...

Descripción completa

Detalles Bibliográficos
Autores principales: khan, Muhammad Tahir, Malik, Shaukat Iqbal, Ali, Sajid, Masood, Nayyer, Nadeem, Tariq, Khan, Anwar Sheed, Afzal, Muhammad Tanvir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364397/
https://www.ncbi.nlm.nih.gov/pubmed/30728001
http://dx.doi.org/10.1186/s12879-019-3764-2
_version_ 1783393262140129280
author khan, Muhammad Tahir
Malik, Shaukat Iqbal
Ali, Sajid
Masood, Nayyer
Nadeem, Tariq
Khan, Anwar Sheed
Afzal, Muhammad Tanvir
author_facet khan, Muhammad Tahir
Malik, Shaukat Iqbal
Ali, Sajid
Masood, Nayyer
Nadeem, Tariq
Khan, Anwar Sheed
Afzal, Muhammad Tanvir
author_sort khan, Muhammad Tahir
collection PubMed
description BACKGROUND: Pyrazinamide (PZA) is an important component of first-line drugs because of its distinctive capability to kill subpopulations of persistent Mycobacterium tuberculosis (MTB). The prodrug (PZA) is converted to its active form, pyrazinoic acid (POA) by MTB pncA-encoded pyrazinamidase (PZase). Mutation in pncA is the most common and primary cause of PZA resistance. The aim of the present study was to explore the molecular characterization of PZA resistance in a Pashtun-dominated region of Khyber Pakhtunkhwa, Pakistan. METHODS: We performed drug susceptibility testing (DST) on 753 culture-positive isolates collected from the Provincial Tuberculosis Control Program Khyber Pakhtunkhwa using the BACTEC MGIT 960 PZA method. In addition, the pncA gene was sequenced in PZA-resistant isolates, and PZA susceptibility testing results were used to determine the sensitivity and specificity of pncA gene mutations. RESULTS: A total of 69 isolates were PZA resistant (14.8%). Mutations were investigated in 69 resistant, 26 susceptible and one H37Rv isolates by sequencing. Thirty-six different mutations were identified in PZA-resistant isolates, with fifteen mutations, including 194_203delCCTCGTCGTG and 317_318delTC, that have not been reported in TBDRM and GMTV Databases and previous studies. Mutations Lys96Thr and Ser179Gly were found in the maximum number of isolates (n = 4 each). We did not detect mutations in sensitive isolates, except for the synonymous mutation 195C > T (Ser65Ser). The sensitivity and specificity of the pncA sequencing method were 79.31% (95% CI, 69.29 to 87.25%) and 86.67% (95% CI, 69.28 to 96.24%). CONCLUSION: Mutations in the pncA gene in circulating isolates of geographically distinct regions, especially in high-burden countries, should be investigated for better control and management of drug-resistant TB. Molecular methods for the investigation of PZA resistance are better than DST.
format Online
Article
Text
id pubmed-6364397
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63643972019-02-15 Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan khan, Muhammad Tahir Malik, Shaukat Iqbal Ali, Sajid Masood, Nayyer Nadeem, Tariq Khan, Anwar Sheed Afzal, Muhammad Tanvir BMC Infect Dis Research Article BACKGROUND: Pyrazinamide (PZA) is an important component of first-line drugs because of its distinctive capability to kill subpopulations of persistent Mycobacterium tuberculosis (MTB). The prodrug (PZA) is converted to its active form, pyrazinoic acid (POA) by MTB pncA-encoded pyrazinamidase (PZase). Mutation in pncA is the most common and primary cause of PZA resistance. The aim of the present study was to explore the molecular characterization of PZA resistance in a Pashtun-dominated region of Khyber Pakhtunkhwa, Pakistan. METHODS: We performed drug susceptibility testing (DST) on 753 culture-positive isolates collected from the Provincial Tuberculosis Control Program Khyber Pakhtunkhwa using the BACTEC MGIT 960 PZA method. In addition, the pncA gene was sequenced in PZA-resistant isolates, and PZA susceptibility testing results were used to determine the sensitivity and specificity of pncA gene mutations. RESULTS: A total of 69 isolates were PZA resistant (14.8%). Mutations were investigated in 69 resistant, 26 susceptible and one H37Rv isolates by sequencing. Thirty-six different mutations were identified in PZA-resistant isolates, with fifteen mutations, including 194_203delCCTCGTCGTG and 317_318delTC, that have not been reported in TBDRM and GMTV Databases and previous studies. Mutations Lys96Thr and Ser179Gly were found in the maximum number of isolates (n = 4 each). We did not detect mutations in sensitive isolates, except for the synonymous mutation 195C > T (Ser65Ser). The sensitivity and specificity of the pncA sequencing method were 79.31% (95% CI, 69.29 to 87.25%) and 86.67% (95% CI, 69.28 to 96.24%). CONCLUSION: Mutations in the pncA gene in circulating isolates of geographically distinct regions, especially in high-burden countries, should be investigated for better control and management of drug-resistant TB. Molecular methods for the investigation of PZA resistance are better than DST. BioMed Central 2019-02-06 /pmc/articles/PMC6364397/ /pubmed/30728001 http://dx.doi.org/10.1186/s12879-019-3764-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
khan, Muhammad Tahir
Malik, Shaukat Iqbal
Ali, Sajid
Masood, Nayyer
Nadeem, Tariq
Khan, Anwar Sheed
Afzal, Muhammad Tanvir
Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title_full Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title_fullStr Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title_full_unstemmed Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title_short Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan
title_sort pyrazinamide resistance and mutations in pnca among isolates of mycobacterium tuberculosis from khyber pakhtunkhwa, pakistan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364397/
https://www.ncbi.nlm.nih.gov/pubmed/30728001
http://dx.doi.org/10.1186/s12879-019-3764-2
work_keys_str_mv AT khanmuhammadtahir pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT malikshaukatiqbal pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT alisajid pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT masoodnayyer pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT nadeemtariq pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT khananwarsheed pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan
AT afzalmuhammadtanvir pyrazinamideresistanceandmutationsinpncaamongisolatesofmycobacteriumtuberculosisfromkhyberpakhtunkhwapakistan